from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2498c/citE

LFCtreatmentdescriptionclass of inhibitor

-0.549

Amikacinug/mL Amikacintranslation

-0.947

Cap5-10ug/mL Capreomycintranslation

-0.817

Rox10-50 ug/mL Roxithromycintranslation

-0.545

SM2-5 ug/mL Streptomycintranslation

-0.506

Tet5-10 ug/mL Tetracyclinetranslation

-0.445

Rif0.2-5ug/mL Rifampicintranscription

-0.974

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.968

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.843

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.368

CPZ10-50 ug/mL Chlorpromazinerespiration

0.471

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.079

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

4.785

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.663

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.122

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.293

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.106

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.812

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.769

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.353

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.014

KCN5-20 ug/mL Potassium cyaniderespiration

-0.617

NaN30.2-2 mM Sodium aziderespiration

0.089

Nigericin50 uM Nigericinrespiration

0.794

TRC10-150 ug/mL Triclosanrespiration

1.728

TRZ10-25 ug/mL Thioridazinerespiration

0.368

Valinomycin0.5-10 uM Valinomycinrespiration

-1.860

ZnSO42 mM ZnSO4respiration

-0.488

menadione6-10 ug/mL Menadionerespiration

-0.354

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.429

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.379

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.737

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.666

NRP_1Non-replicating persistence stage 1dosRassociated

-0.540

Amp0.2mg/mL AmpicillincellWall

-0.485

Cephalexin20-100 ug/mL CephalexincellWall

-0.392

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.233

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.383

EMB10-20 ug/mL EthambutolcellWall

-0.396

Eta12-40 ug/mL EthionamidecellWall

-0.320

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.267

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.698

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.288

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.075

BZA0.12 mg/mL BenzamidearomaticAmides

-0.248

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.403

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.109

H2O24 mM hydrogen peroxideDNAdamaging

-0.562

Levo10 ug/mL LevofloxacinDNAdamaging

-0.244

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.695

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.616

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.346

UVUV-irradiationDNAdamaging

-0.365

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.513

Antimycin12.5-50 ug/mL Antimycin A?

-0.608

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.390

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.326

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.500

PA8240.2-2 ug/mL PA-824?

0.810

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.266

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.376

Verapamil50 uM Verapamil?

-0.314

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.794

methoxatin10-20 ug/mL Methoxatin?